Quantity Add to cart Inquiry
| Product Name | Biotinylated Human HLA-A*01:01&B2M&MAGE-A3 Monomer |
| Cat. No. | MHCRP-0337 |
| Category | Proteins & Peptides |
| Product Description | Recombinant Biotinylated Human HLA-A*01:01&B2M&MAGE-A3 (EVDPIGHLY) Monomer Protein is expressed from HEK293 with His tag and Avi Tag at the C-terminus. It contains Gly25-Thr305 (HLA-A*01:01), Ile21-Met119 (B2M) and EVDPIGHLY peptide. |
| Size | 100/500 μg |
| Format | Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
| Storage | Store at -20 to -80°C for 12 months as supplied from date of receipt. -80°C for 3 months after reconstitution. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles. |
| Shipping Temp | Shipped at ambient temperature. |
| Lead Time | Product delivery time depends on the supplier. |
| Species | Human |
| Expression Host | HEK293 |
| Accession No | Q5SUL5(HLA-A*01:01)&P61769(B2M)&EVDPIGHLY |
| Tag | C-His-Avi |
| Tag Position | C-terminus |
| Molecular Type | Monomer |
| Molecular Weight (MV) | The protein has a predicted MW of 50.30 kDa. Due to glycosylation, the protein migrates to 53-63 kDa based on Bis-Tris PAGE result. |
| Gene Synonyms | Melanoma-associated antigen 3; MZ2-D; MZ2D; MZ2-D; CT1.3; MAGE-3 |
| Purity | > 95% as determined by Bis-Tris PAGE; > 95% as determined by HPLC. |
| Amino Acid Range | Gly25-Thr305 (HLA-A*01:01), Ile21-Met119 (B2M), and EVDPIGHLY peptide |
| Activity | Immobilized biotinylated human HLA-A*01:01&B2M&MAGE-A3 (EVDPIGHLY) monomer, His tag at 1 μg/mL (100 μL/well) on the streptavidin precoated plate (5 μg/mL). Dose response curve for anti-B2M antibody, mFc tag with the EC50 of 10.9 ng/mL determined by ELISA (QC Test). |
| Product Background | Melanoma antigen gene A3 (MAGE-A3) is one of the most immunogenic cancer testis antigens and is common in various types of cancers. MAGE-A3 can be considered as a predictor for poor prognosis and an option for vaccine immunotherapy in patients with PCA. |
| Allele | HLA-A*01:01 |
| Biotinylated | Yes |
Tel:
One-stop service